14248-01-2

Usage

Uses

Used in Pharmaceutical Industry:
5-Bromo-1-methylpyrimidin-2-one is used as an intermediate in the synthesis of various pharmaceutical compounds for [application reason]. Its unique structure and reactivity make it a valuable building block in the development of new drugs with specific therapeutic properties.
Used in Agrochemical Industry:
In the agrochemical industry, 5-Bromo-1-methylpyrimidin-2-one is used as a key component in the production of [application type] for [application reason]. Its chemical properties allow for the creation of effective agrochemicals that can address various agricultural challenges.
Used in Chemical Research:
5-Bromo-1-methylpyrimidin-2-one is utilized as a research compound in chemical laboratories for [application reason]. Its unique structure and potential reactivity make it an interesting subject for studying various chemical reactions and processes, contributing to the advancement of scientific knowledge in the field.
Used in Industrial Processes:
5-broMo-1-MethylpyriMidin-2-one is employed in various industrial processes as a [application type] for [application reason]. Its specific properties and reactivity can be harnessed to improve the efficiency and effectiveness of certain manufacturing processes, leading to the production of high-quality products.

InChI:InChI=1/C5H5BrN2O/c1-8-3-4(6)2-7-5(8)9/h2-3H,1H3

Upstream product

• 38353-06-9 5-bromo-1H-pyrimidin-2-one 
• 74-88-4 methyl iodide 
• 63331-67-9 2-bromo-1,1,3,3-tetramethoxy-propane 
• 81590-30-9 5-bromo-2-hydroxypyrimidine hydrobromide 

Downstream Products

• 103594-74-7 5-bromo-3,4-dihydro-4-(4-methoxyphenyl)-1-methylpyrimidin-2(1H)one 
• 1458655-47-4 5-(4-amino-3,5-dimethylphenyl)-1-methylpyrimidin-2(1H)-one 
• 103594-82-7 5-bromo-4-(4-methoxyphenyl)-1-methylpyrimidin-2(1H)-one 

Relevant academic research and scientific papers

FACTOR IXA INHIBITORS

In its many embodiments, the present invention provides a novel class of benzamide compounds represented by Formula (I) or pharmaceutically acceptable salts or solvates thereof, or pharmaceutical compositions comprising one or more said compounds or pharmaceutically acceptable salts or solvates thereof, and methods for using said compounds or pharmaceutically acceptable salts or solvates thereof for treating or preventing a thromboses, embolisms, hypercoagulability or fibrotic changes.

FACTOR IXA INHIBITORS

In its many embodiments, the present invention provides a novel class of benzamide compounds represented by Formula (I) or pharmaceutically acceptable salts or solvates thereof, or pharmaceutical compositions comprising one or more said compounds or pharmaceutically acceptable salts or solvates thereof, and methods for using said compounds or pharmaceutically acceptable salts or solvates thereof for treating or preventing a thromboses, embolisms, hypercoagulability or fibrotic changes.

NEW INDANYLOXYDIHYDROBENZOFURANYLACETIC ACIDS

The present invention relates to compounds of general formula I, wherein the groups R1, R2 and m are defined as in claim 1, which have valuable pharmacological properties, in particular bind to the GPR40 receptor and modulate its activity. The compounds are suitable for treatment and prevention of diseases which can be influenced by this receptor, such as metabolic diseases, in particular diabetes type 2.

NEW INDANYLOXYDIHYDROBENZOFURANYLACETIC ACID DERIVATIVES AND THEIR USE AS GPR40 RECEPTOR AGONISTS

The present invention relates to compounds of general formula I, (I), wherein the groups R1, R2 and m are defined as in claim 1, which have valuable pharmacological properties, in particular bind to the GPR40 receptor and modulate its activity. The compounds are suitable for treatment and prevention of diseases which can be influenced by this receptor, such as metabolic diseases, in particular diabetes type 2.

SUBSTITUTED PYRIDONE DERIVATIVE

Compounds of a formula (I) [wherein, A represents formula (III-1) R3 is a hydrogen, lower alkyl et al; m is 0 or 1; R1 is a hydrogen atom, halogen atom et al, R2 is a hydrogen et al; p is 0 to 4; X is a carbon atom or nitrogen atom; and X1 to X4 is a lowe

SUBSTITUTED PYRIDONE DERIVATIVE

Compounds of the formula: (I) [wherein A is the formula: (III-1) R3 is a hydrogen atom, lower alkyl, etc.; m is 0 or 1; R1 is a hydrogen atom, halogen atom, etc.; R2 is a hydroxyl, etc.; p is 0 to 4; X is a carbon atom or

5-Halopyrimid-2-ones

Novel derivatives of pyrimid-2-one having interesting pharmacological properties are described. The compounds of the invention have been found to be of use in the control of, and in particular in the inhibition of the metaphase of malignant tumours and le